health · 12 min read

Sleep Apnea Risk Screener: Signs, Scores & Next Steps

Sleep apnea risk screener guide: understand STOP-BANG scores, spot key symptoms, and learn when to seek diagnosis with our sleep apnea risk screener.

Published 5/19/2026

Ad slot · Sponsored · (Set VITE_ADSENSE_CLIENT to enable AdSense)

Obstructive sleep apnea (OSA) is one of the most prevalent and most underdiagnosed sleep disorders in the world. Its global prevalence ranges from 17% to roughly 40% of the population depending on the diagnostic threshold applied — yet the vast majority of patients remain undiagnosed. Ninety-three percent of women with moderate-to-severe OSA have not received a diagnosis. Even among men, where recognition is better, diagnosis rates are poor.

The consequences of leaving sleep apnea undiagnosed and untreated are serious: untreated severe sleep apnea increases the risk of cardiovascular death by three times. People with OSA are 71% more likely to develop cardiovascular disease, 48% more likely to develop coronary heart disease, and 2.5 times more likely to be involved in a motor vehicle accident. A person with untreated sleep apnea is three times more likely to die compared to those without the condition, according to the American Academy of Sleep Medicine.

A sleep apnea risk screener is not a diagnosis — only a sleep study (polysomnography or home sleep apnea test) can provide that. But it is a validated, evidence-based tool that can identify people at high enough risk to warrant formal evaluation, saving years of unrecognised suffering and potentially preventing serious cardiovascular and metabolic disease.

This article explains how sleep apnea risk screening works, what the standard screening tools measure and how to interpret them, what the clinical consequences of undiagnosed OSA are, and the clear pathway from a positive screen to a confirmed diagnosis and treatment.

Sleep Apnea Risk Screener: Understanding What Your Results Mean

What Is Obstructive Sleep Apnea?

Obstructive sleep apnea is a sleep-related breathing disorder characterised by repeated, partial or complete collapses of the upper airway during sleep. Each collapse — called an apnea (complete) or hypopnea (partial) — results in a brief pause in breathing lasting 10 seconds or more, a drop in blood oxygen levels, and an arousal from sleep (usually subconscious) that restores airway patency and breathing.

These events are measured by the Apnea-Hypopnea Index (AHI) — the number of apnea and hypopnea events per hour of sleep:

AHI score	OSA severity
< 5 events/hour	Normal (no OSA)
5–14 events/hour	Mild OSA
15–29 events/hour	Moderate OSA
≥ 30 events/hour	Severe OSA

A person with severe OSA may experience 30 or more complete breathing pauses per hour — one every two minutes throughout their sleep — each accompanied by an oxygen desaturation and a micro-arousal that fragments sleep architecture without necessarily waking the person fully.

This is the critical mechanism through which sleep apnea creates sleep debt: even when a person with OSA spends eight hours in bed, their sleep is so severely fragmented that they never achieve the sustained periods of slow-wave sleep and REM sleep needed for genuine biological restoration. They may have minimal measurable sleep debt by duration — but enormous effective sleep debt by quality.

Use the Sleep Apnea Risk Screener to assess your risk level before reading further, then return to this article to understand your result.

The STOP-BANG Questionnaire: The Most Validated Screening Tool

The STOP-BANG questionnaire is the most widely used, most clinically validated, and most internationally recognised screening tool for obstructive sleep apnea. It was developed to identify individuals at high risk of OSA across general and clinical populations, and is used in pre-operative anaesthetic assessment, primary care, and sleep medicine settings worldwide.

A 2024 Applied Sciences study confirmed that the STOP-BANG questionnaire is widely recognised as a simple yet effective tool for diagnosing and assessing the risk of sleep apnea, and a 2024 Frontiers in Neurology study demonstrated that high STOP-BANG scores independently predict cardiovascular morbidity.

The eight STOP-BANG questions

Each question is answered Yes (1 point) or No (0 points):

Letter	Question
S — Snoring	Do you snore loudly (louder than talking, or loud enough to be heard through closed doors)?
T — Tired	Do you often feel tired, fatigued, or sleepy during the daytime?
O — Observed	Has anyone observed you stop breathing during your sleep?
P — Pressure	Do you have or are you being treated for high blood pressure?
B — BMI	Is your BMI greater than 35?
A — Age	Are you older than 50?
N — Neck	Is your neck circumference greater than 40 cm (15.75 inches)?
G — Gender	Are you male?

Interpreting your STOP-BANG score

Score	Risk level	Clinical interpretation
0–2	Low risk	OSA unlikely — maintain awareness of symptoms
3–4	Intermediate risk	OSA possible — discuss with physician if symptomatic
5–8	High risk	OSA probable — formal sleep evaluation recommended

Important scoring notes:

A score of 3 or more, combined with answering Yes to two or more of the first four questions (S, T, O, P), significantly increases the probability of moderate-to-severe OSA specifically. A score of 5 or more on the full STOP-BANG is associated with a high probability of clinically significant OSA requiring treatment.

The 2024 Frontiers in Neurology study found that among 6,630 participants, the high-risk STOP-BANG group showed a significantly higher prevalence of cardiovascular morbidity (11.9%) compared to the low- and intermediate-risk groups — confirming the questionnaire's ability to identify not just OSA risk but broader cardiometabolic risk.

Limitations of the STOP-BANG

The STOP-BANG is a screening tool, not a diagnostic test. Its sensitivity (ability to correctly identify those who have OSA) is high, but its specificity (ability to correctly identify those who do not) is more limited — meaning it produces false positives. The definitive diagnosis of OSA requires a sleep study. A high STOP-BANG score indicates that a sleep study is warranted; it does not confirm OSA.

Additionally, the STOP-BANG was originally developed in surgical populations and may perform differently in other groups. A 2025 Scientific Reports study comparing five OSA screening questionnaires in elderly patients found that the STOP-BANG performed reasonably well but that other tools may be more appropriate for specific subgroups.

Other Validated Screening Approaches

Beyond the STOP-BANG, several other tools are used in OSA screening:

Berlin Questionnaire

The Berlin Questionnaire categorises OSA risk across three domains: snoring (frequency, loudness, observed apneas), daytime sleepiness (frequency, tiredness, drowsy driving), and hypertension or obesity. A high score in two or more categories indicates high OSA risk. It is widely used in primary care and epidemiological research but is longer than the STOP-BANG and slightly less sensitive for moderate-to-severe OSA in clinical settings.

Epworth Sleepiness Scale (ESS)

The ESS (covered in our Sleep Debt Signs article) measures daytime sleepiness across eight common scenarios. An ESS score above 10 indicates excessive daytime sleepiness that may suggest OSA — particularly when combined with other OSA symptoms. It is commonly used alongside the STOP-BANG in clinical screening rather than as a standalone tool.

WatchPAT and Home Sleep Apnea Tests (HSAT)

For people who score high on questionnaire-based screening, home sleep apnea tests — portable devices worn at home that measure respiratory effort, oxygen saturation, pulse, and body position — represent the next step before or instead of full polysomnography. Home sleep apnea tests have a sensitivity of roughly 80% for moderate-to-severe cases and are increasingly used as the first-line diagnostic step because of their accessibility and lower cost compared to in-lab studies. Use the Sleep Apnea Risk Screener as your first step, then discuss HSAT options with your physician if your score is high.

The Key Risk Factors for Sleep Apnea

Understanding which risk factors drive OSA is important both for interpreting your screener score and for understanding whether your risk level is likely to increase over time.

Anatomical and physiological factors

Upper airway anatomy is the most fundamental driver of OSA risk. Structural features that narrow or predispose the airway to collapse include: retrognathia (recessed jaw), enlarged tonsils or adenoids, a thick neck, macroglossia (enlarged tongue), and nasal obstruction. These factors are partially genetic and partially modifiable through weight management and, in some cases, surgical or dental intervention.

Neck circumference is one of the most reliable single predictors of OSA risk. The STOP-BANG threshold of 40 cm reflects research showing that larger neck circumference is associated with increased fatty tissue deposition around the pharynx, which narrows airway dimensions and increases collapse risk during the muscle relaxation of sleep.

Weight and obesity

Obesity is the strongest modifiable risk factor for OSA. Up to 50% of obese adults have OSA. Weight gain in the neck and upper body increases pharyngeal fat deposition and reduces chest wall compliance — both of which promote airway collapse during sleep. A 2024 systematic review (Preventive Medicine Reports) confirmed that obesity is consistently the most significant risk factor across global study populations.

Every 10% increase in body weight is associated with a six-fold increase in OSA risk. Conversely, weight loss — even 10–15% of body weight — significantly reduces OSA severity, and major weight loss (through bariatric surgery or GLP-1 agonist therapy) can produce complete or near-complete OSA remission in many patients.

Age

OSA prevalence increases substantially with age. The structural changes of aging — reduced muscle tone, tissue changes in the pharynx, and shifts in fat distribution — all promote airway collapsibility. The STOP-BANG threshold of age over 50 reflects the marked increase in OSA prevalence from middle age onward. Among adults 65 and older, OSA prevalence is estimated at 40–80% depending on the diagnostic threshold.

Sex

Men have approximately twice the OSA prevalence of premenopausal women — due to differences in upper airway anatomy, fat distribution patterns, and ventilatory control mechanisms. However, after menopause, women's OSA risk increases substantially and approaches male prevalence. The striking figure — 93% of women with moderate-to-severe OSA remain undiagnosed — reflects both the historical male bias in OSA research and the tendency for women to present with atypical symptoms (fatigue, insomnia, depression) rather than the classic male presentation of loud snoring and witnessed apneas.

Alcohol, sedatives, and muscle relaxants

Alcohol is a significant OSA trigger even in people without underlying anatomical risk. It relaxes the pharyngeal muscles responsible for maintaining airway patency, promotes airway collapse, and suppresses the arousal response that normally restores breathing after an apnea event — meaning apneas are both more frequent and longer after alcohol consumption. Sedatives and benzodiazepines act through similar mechanisms.

People with borderline OSA who drink regularly before bed may have significant OSA on those nights while falling below diagnostic thresholds on alcohol-free nights. This explains why some people experience prominent OSA symptoms (snoring, fragmented sleep, morning headache) specifically on nights when they have consumed alcohol.

Positional factors

Sleeping supine (on the back) is associated with worse OSA in most patients. Gravity pulls the tongue and soft palate posteriorly, narrowing the airway. Many patients have exclusively positional OSA — events occurring only or predominantly in the supine position — which responds well to positional therapy (sleeping on the side) as a treatment component.

Nasal congestion and allergies

Nasal obstruction increases OSA severity by increasing inspiratory resistance and forcing mouth breathing, which promotes posterior tongue displacement and airway collapse. Effective management of chronic rhinitis, nasal polyps, and seasonal allergies can meaningfully reduce OSA severity in patients with significant nasal obstruction.

The Health Consequences of Undiagnosed Sleep Apnea

Cardiovascular disease: the most documented risk

The cardiovascular consequences of untreated OSA are the most extensively researched and most clinically significant:

OSA is associated with a 71% increased risk of cardiovascular disease overall
A 48% increased risk of coronary heart disease specifically
A four-times higher risk of stroke in severe OSA compared to those without OSA
OSA prevalence is 40–80% in patients with hypertension, heart failure, coronary artery disease, pulmonary hypertension, atrial fibrillation, and stroke — confirming its role as both a consequence and a driver of cardiac pathology (American Heart Association Scientific Statement)
Up to 74% of people with atrial fibrillation have concurrent sleep apnea
Up to 50% of OSA patients have high blood pressure; people with moderate OSA are 180% more likely to be diagnosed with hypertension

The mechanism is multi-pathway: repeated oxygen desaturations activate the sympathetic nervous system, elevate cortisol, promote oxidative stress and systemic inflammation, impair endothelial function, and prevent the normal nighttime blood pressure dipping that is protective against cardiovascular events.

Metabolic disease

The metabolic consequences of OSA are closely related to and independent of obesity:

Up to 67% of people with OSA may have prediabetes
An estimated 83% of people with Type 2 Diabetes have sleep apnea
OSA is linked to insulin resistance through intermittent hypoxia and cortisol elevation — mechanisms that operate independently of body weight
Untreated OSA can cause blood sugar spikes within hours of falling asleep, confirmed in CPAP intervention studies

Mental health

A 2025 Depression and Anxiety study (Kao et al., TriNetX US Network, 30,097 participants) found that OSA significantly increases the risk of developing depression, anxiety disorder, bipolar disorder, and schizophrenia. The mechanism involves intermittent hypoxia-driven brain damage and emotional regulation disruption from sleep fragmentation.

A 2024 CHEST study by Kendzerska et al. (Canadian Longitudinal Study on Aging, 30,097 participants) consistently found a relationship between OSA risk and mental health conditions — confirming the association across different populations and methodologies.

OSA patients have a two-fold increased risk of developing depression compared to those without OSA.

Cognitive function and dementia risk

OSA-related sleep fragmentation prevents the sustained slow-wave sleep needed for glymphatic clearance of beta-amyloid and tau proteins — the same mechanism through which chronic sleep deprivation elevates dementia risk. Cognitive impairment is observed in 25% of patients with mild to moderate OSA. Severe OSA is associated with measurable reductions in grey matter in the hippocampus and prefrontal cortex — regions critical for memory, decision-making, and emotional regulation.

Accident risk

OSA patients are 2.5 times more likely to be the driver in a motor vehicle accident compared to people without OSA. Motor vehicle accidents related to sleep apnea cost an estimated $15.9 billion annually in the United States. OSA is associated with a two-fold increased risk of workplace injuries. These risk figures are directly attributable to the daytime sleepiness, microsleep episodes, and impaired reaction time produced by sleep fragmentation.

Sleep debt amplification

This is the critical connection between OSA and sleep debt: OSA does not just cause sleepiness — it prevents the biological restoration that sleep is supposed to provide. A person with severe untreated OSA sleeping eight hours may be getting the effective biological restoration of four to five hours, because their sleep is so severely fragmented by apnea events that slow-wave and REM stages are perpetually interrupted.

This means that standard sleep debt calculations — which measure hours of sleep against a duration target — significantly underestimate the true debt of an OSA patient. If you are calculating your sleep debt using the Sleep Debt Calculator and your score is consistently low but you still feel severely fatigued and unrested, OSA should be considered as an explanation. The Sleep Apnea Risk Screener is the right next tool to use.

The Pathway from Screening to Diagnosis and Treatment

Step 1: Complete a validated screener

Use the Sleep Apnea Risk Screener for your initial assessment. If you prefer to use the STOP-BANG directly, score yourself on the eight questions above and note your total.

Low risk (0–2): OSA is unlikely. Maintain awareness of symptoms — particularly if you gain weight, develop hypertension, or notice new or worsening snoring. Rescreen annually or if circumstances change.

Intermediate risk (3–4): Discuss your score and symptoms with your primary care physician. A clinical assessment — examining airway anatomy, blood pressure, and symptom severity — will determine whether a sleep study is warranted.

High risk (5–8): A formal sleep evaluation is recommended. Ask your physician for a referral to a sleep medicine specialist or request a home sleep apnea test. Do not wait for symptoms to become unbearable — OSA can be significantly symptomatic or nearly asymptomatic while still driving serious cardiovascular and metabolic damage.

Step 2: Choose the appropriate diagnostic test

Polysomnography (PSG) is the gold standard for OSA diagnosis, performed in a sleep laboratory with comprehensive monitoring of respiratory effort, airflow, oxygen saturation, EEG (sleep staging), EMG, ECG, and body position. It achieves 95% diagnostic accuracy. It is recommended when co-morbid sleep disorders (periodic limb movement disorder, parasomnias, narcolepsy) are suspected alongside OSA, or when a home test has been inconclusive.

Home Sleep Apnea Test (HSAT) is a portable, ambulatory device worn at home that measures the key parameters needed to diagnose OSA: respiratory effort, airflow, oxygen saturation, pulse, and often body position. It has a sensitivity of roughly 80% for moderate-to-severe cases. It is less comprehensive than PSG but significantly more accessible, more affordable, and more comfortable — making it the appropriate first-line diagnostic step for most adults with intermediate-to-high STOP-BANG scores and no suspected co-morbid sleep disorders.

Step 3: Understand treatment options

CPAP (Continuous Positive Airway Pressure) is the most effective treatment for moderate-to-severe OSA. It delivers a continuous stream of pressurised air through a mask worn during sleep, creating a pneumatic splint that holds the airway open and eliminates apnea and hypopnea events. CPAP therapy is effective in 95% of patients when used correctly. CPAP therapy can reduce the risk of cardiovascular death by 37%, lower mean 24-hour blood pressure by 2–3 mmHg, and significantly improve daytime sleepiness, cognitive function, and quality of life.

The main challenge is adherence: 30 to 50% of patients fail to comply with CPAP treatment within the first year. Modern CPAP machines are quieter, more data-connected, and more comfortable than their predecessors, and significant advances in mask design, auto-titrating pressure (APAP), and heated humidification have substantially improved the adherence picture.

Oral appliance therapy is used by approximately 10% of sleep apnea patients as an alternative to CPAP — particularly for mild-to-moderate OSA and positional OSA. Mandibular advancement devices (MADs) reposition the lower jaw and tongue forward, increasing airway dimensions and reducing collapsibility. They are less effective than CPAP at severe AHI levels but are more acceptable to many patients and show meaningful AHI reduction in appropriate candidates.

Positional therapy for position-dependent OSA (events predominantly in the supine position) can significantly reduce AHI through consistently maintaining the side-sleeping position. Several devices and pillows are specifically designed for this purpose.

Weight loss is the most effective long-term treatment for obesity-related OSA. Major weight loss — whether through lifestyle change, GLP-1 agonist therapy, or bariatric surgery — can produce clinically meaningful and sometimes complete OSA remission. The 2025 Lancet Respiratory Medicine systematic review confirmed that positive airway pressure therapy reduces all-cause and cardiovascular mortality in OSA patients — with the magnitude of benefit related to treatment adherence and OSA severity.

Step 4: Monitor sleep quality and debt after treatment

Effective OSA treatment — particularly CPAP — typically produces dramatic improvements in daytime energy, cognitive function, mood, and sleep quality within days to weeks of consistent use. However, years of untreated OSA may leave residual sleep debt and health consequences that require additional time to resolve.

Track your sleep quality using the Sleep Quality Score and recalculate your sleep debt weekly after starting treatment to confirm that your effective debt is declining. Some patients find that CPAP resolves their apparent sleep debt rapidly; others find that residual fatigue persists and may indicate that CPAP pressure needs optimisation, that another sleep disorder is co-present, or that the long-term health consequences of their OSA require additional management.

Use the Sleep Recovery Planner to build a structured recovery plan following OSA diagnosis and treatment initiation.

Frequently Asked Questions

What is a sleep apnea risk screener?

A sleep apnea risk screener is a validated questionnaire-based tool that identifies individuals at elevated risk of obstructive sleep apnea based on known risk factors and symptoms. The most widely used is the STOP-BANG questionnaire, which scores eight yes/no questions — Snoring, Tiredness, Observed apneas, Pressure (hypertension), BMI above 35, Age over 50, Neck circumference, and Gender (male). Scores of 5–8 indicate high risk warranting formal sleep evaluation. The Sleep Apnea Risk Screener provides an accessible, digital version of this assessment.

What are the main symptoms of sleep apnea?

The classic symptom cluster is: loud snoring (often reported by a bed partner), witnessed breathing pauses during sleep, abrupt awakenings with gasping or choking, and excessive daytime sleepiness. Additional symptoms include morning headaches, difficulty concentrating, irritability, frequent nocturnal urination (nocturia), and non-restorative sleep — waking unrefreshed despite adequate time in bed. Women with OSA more commonly present with atypical symptoms — fatigue, insomnia, depression, and anxiety — without prominent snoring, contributing to the high rate of under-diagnosis in women.

Can I have sleep apnea without snoring?

Yes. While snoring is the most commonly recognised symptom of OSA, not all people with OSA snore loudly, and not all snorers have OSA. Silent OSA — characterised primarily by daytime fatigue, cognitive impairment, and non-restorative sleep without prominent snoring — is more common in women, children, and people with central sleep apnea (where the mechanism is a failure of the brain's respiratory control system rather than mechanical airway obstruction). A STOP-BANG score that is high despite answering No to snoring should still prompt evaluation.

How does sleep apnea cause sleep debt?

Sleep apnea causes sleep debt not primarily through duration reduction but through quality impairment. Each apnea event causes a micro-arousal — a brief activation of the brain that fragments sleep architecture and prevents sustained slow-wave deep sleep and REM sleep. A person with severe OSA experiencing 40 apnea events per hour may have hundreds of micro-arousals per night, none of which they consciously recall, but each of which prevents the deep restorative stages of sleep from completing. The result is severe effective sleep debt even when time in bed appears adequate. The Sleep Apnea Risk Screener is therefore an important complement to the Sleep Debt Calculator for people with persistent fatigue despite apparently sufficient sleep hours.

What happens if sleep apnea is left untreated?

Untreated severe sleep apnea is associated with a three-fold increased risk of cardiovascular death, a four-fold increased risk of stroke, significantly elevated risks of hypertension, Type 2 Diabetes, depression, and cognitive decline, and a 2.5-fold increased risk of motor vehicle accidents. The long-term mortality risk of untreated severe OSA is substantial — comparable to or exceeding the cardiovascular risk from smoking.

Is CPAP the only treatment for sleep apnea?

No. CPAP is the most effective treatment for moderate-to-severe OSA and remains the clinical gold standard, but it is not the only option. Oral appliance therapy (mandibular advancement devices) is effective for mild-to-moderate OSA. Positional therapy helps patients with position-dependent OSA. Significant weight loss can dramatically reduce or eliminate OSA in obesity-related cases. Surgical options (uvulopalatopharyngoplasty, maxillomandibular advancement, hypoglossal nerve stimulation) are appropriate for specific anatomical presentations. The right treatment depends on OSA severity, anatomical factors, and patient preference — a sleep medicine specialist can guide the appropriate pathway.

How accurate is the STOP-BANG questionnaire?

The STOP-BANG is highly sensitive — meaning it correctly identifies most people who have OSA — but less specific, meaning it also flags some people who do not have OSA as high-risk. A 2024 Applied Sciences machine learning analysis of STOP-BANG confirmed its utility while noting that its specificity limitations mean it should be used to identify people warranting further evaluation, not to diagnose OSA. A high STOP-BANG score indicates that a sleep study is warranted. A low STOP-BANG score makes clinically significant OSA less likely but does not fully exclude it, particularly in women with atypical presentations.

The Bottom Line

Obstructive sleep apnea is common, underdiagnosed, and carries serious health consequences — including cardiovascular disease, metabolic syndrome, mental health disorders, cognitive impairment, and substantially elevated mortality risk. A sleep apnea risk screener is the fastest, most accessible first step toward identifying whether you are at risk and should pursue formal diagnosis.

The pathway is clear: use the Sleep Apnea Risk Screener to assess your risk, interpret your score using the STOP-BANG framework in this article, and if you score intermediate or high, discuss the result with your physician and request a home sleep apnea test or sleep medicine referral.

If you are carrying persistent sleep debt despite apparently adequate sleep hours — if the Sleep Debt Calculator shows a low score but you still feel chronically unrefreshed and fatigued — OSA is one of the most important conditions to rule out, because it silently converts adequate sleep duration into inadequate sleep restoration, invisibly and relentlessly, every night it goes unaddressed.

Tools Referenced in This Article

Sleep Apnea Risk Screener — Assess your OSA risk level
Sleep Debt Calculator — Calculate your weekly sleep deficit
Sleep Quality Score — Track sleep quality after OSA treatment
Insomnia Self-Assessment — Screen for insomnia disorder alongside OSA
Sleep Recovery Planner — Structured recovery following OSA diagnosis

References

American Academy of Sleep Medicine. Sleep apnea information for clinicians. aasm.org. Accessed May 2026. https://aasm.org/clinical-resources/clinical-guidelines/
CPAP.com. 2025 sleep apnea statistics: prevalence, risks, and key facts. 2025. https://www.cpap.com/blogs/sleep-apnea/sleep-apnea-statistics
Wifitalents. Sleep apnea: data reports 2026. https://wifitalents.com/sleep-apnea-statistics/
Kang J, Koo HK, Kang HK, Seo WJ, Kang J, Kim J. Prevalence of high-risk group for OSA using the STOP-Bang questionnaire and its association with cardiovascular morbidity. Frontiers in Neurology. 2024. doi:10.3389/fneur.2024.1394345. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11663855/
Li et al. MDPI Applied Sciences. A study on improving sleep apnea diagnoses using machine learning based on the STOP-BANG questionnaire. Applied Sciences. 2024;14(7):3117. doi:10.3390/app14073117. https://www.mdpi.com/2076-3417/14/7/3117
Gami N, et al. Epidemiological study of sleep apnea prevalence and associated risk factors. Journal of Pharmacy and Bioallied Sciences. 2024;16(Suppl 3):S2721–S2723. doi:10.4103/jpbs.jpbs_426_24. https://pmc.ncbi.nlm.nih.gov/articles/PMC11426764/
Yayan J, et al. A systematic review of risk factors for sleep apnea. Preventive Medicine Reports. 2024;42:102750. doi:10.1016/j.pmedr.2024.102750. https://pubmed.ncbi.nlm.nih.gov/38741931/
Evaluation of five questionnaires for OSA screening in the elderly. Scientific Reports. 2025;15:1689. doi:10.1038/s41598-025-86041-8. https://pmc.ncbi.nlm.nih.gov/articles/PMC11724924/
Toward developing more effective screening questionnaires for obstructive sleep apnoea. PMC/NCBI. 2025. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12904888/
Advancements in OSA diagnosis and screening through AI: a systematic review. PMC/NCBI. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC11764519/
Somers VK, et al. Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;144:e56–e67. doi:10.1161/CIR.0000000000000988. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000988
Lancet Respiratory Medicine. Positive airway pressure therapy and all-cause and cardiovascular mortality in OSA: a systematic review and meta-analysis. 2025. doi:10.1016/S2213-2600(25)00002-5. https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00002-5/abstract
Kao CY, et al. The population-based risk of obstructive sleep apnea and psychiatric conditions. Depression and Anxiety. 2025;2025:4329208. doi:10.1155/da/4329208. https://pmc.ncbi.nlm.nih.gov/articles/PMC12626701/
Kendzerska T, et al. The relationship between concurrent mental health disorders and sleep-disordered breathing. CHEST. 2024;166(4):A6194–A6195. https://www.ajmc.com/view/dr-tetyana-kendzerska-chest-data-highlight-connection-between-sleep-apnea-and-mental-health
Harvard Division of Sleep Medicine. Sleep and health — cardiovascular disease. sleep.hms.harvard.edu. https://sleep.hms.harvard.edu/education-training/public-education/sleep-and-health-education-program/sleep-health-education-86
Borsini E, et al. Sleep disordered breathing challenges: from diagnosis to treatment. Sleep Science. PMC6201518. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201518/

Disclaimer: This article is for educational and informational purposes only and does not constitute medical advice. A sleep apnea risk screener identifies risk — it does not diagnose. If you score intermediate or high, please consult a qualified healthcare professional or a board-certified sleep medicine specialist for formal evaluation.